(Q38410380)

English

Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

scientific article published on August 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal (English)

1 reference

Europe PubMed Central

2 September 2017

alcohol consumption

0 references

alcohol dependence

1 reference

based on heuristic

inferred from title

Abdullah Pandor

2

1 reference

Europe PubMed Central

2 September 2017

John W. Stevens

object named as

John W Stevens

3

0 references

author name string

Matt Stevenson

1

1 reference

Europe PubMed Central

2 September 2017

Andrew Rawdin

4

1 reference

Europe PubMed Central

2 September 2017

Peter Rice

5

1 reference

Europe PubMed Central

2 September 2017

Jez Thompson

6

1 reference

Europe PubMed Central

2 September 2017

Marsha Y Morgan

7

1 reference

Europe PubMed Central

2 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2015

1 reference

Europe PubMed Central

2 September 2017

PharmacoEconomics

1 reference

Europe PubMed Central

2 September 2017

33

1 reference

Europe PubMed Central

2 September 2017

8

1 reference

Europe PubMed Central

2 September 2017

833-847

1 reference

Europe PubMed Central

2 September 2017

https://scigraph.springernature.com/pub.10.1007/s40273-015-0272-0

0 references

Addiction is a brain disease, and it matters

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0272-0

21 January 2018

Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0272-0

21 January 2018

Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studies

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0272-0

21 January 2018

A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0272-0

21 January 2018

Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0272-0

21 January 2018

Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0272-0

21 January 2018

Targeted naltrexone for problem drinkers

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0272-0

21 January 2018

Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives

2 references

https://api.crossref.org/works/10.1007%2FS40273-015-0272-0

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/25851485

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Credibility of claims of subgroup effects in randomised controlled trials: systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0272-0

21 January 2018

Patterns of outcome: drinking histories over ten years among a group of alcoholics

1 reference

https://pubmed.ncbi.nlm.nih.gov/25851485

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Talk is cheap: measuring drinking outcomes in clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/25851485

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An experimental study of the agreement of self-administration and telephone administration of the Timeline Followback interview.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25851485

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted versus daily naltrexone: secondary analysis of effects on average daily drinking

1 reference

https://pubmed.ncbi.nlm.nih.gov/25851485

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted naltrexone for early problem drinkers

1 reference

https://pubmed.ncbi.nlm.nih.gov/25851485

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alcohol-related problems: recognition and intervention.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25851485

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40273-015-0272-0

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38410380&oldid=1757954689"